To improve the quality of medical care in developing countries, a new partnership between the American Society of Hematology (ASH) and Health Volunteers Overseas (HVO) aims to recruit and support physician volunteers to educate and train health-care providers in those countries on the treatment of patients with blood disorders.
High-tech dental lasers used mainly to prepare cavities for restoration now can help eliminate bacteria in root canals, according to research published in the July issue of The Journal of the American Dental Association (JADA).
Further to a warning issued on June 29, Health Canada is warning Canadians not to use a counterfeit product falsely labelled as Colgate Fluoride Toothpaste Maximum Cavity Protection. Ongoing testing has resulted in preliminary evidence of a further, potentially harmful bacterial contamination.
A study appearing in the July issue of the Journal of Periodontology found bacteria commonly found in the mouth and associated with periodontal diseases in the amniotic fluid of some pregnant women.
Health Canada is warning Canadians that counterfeit toothpaste products, falsely labelled as Colgate Fluoride Toothpaste Herbal and Colgate Fluoride Toothpaste Maximum Cavity Protection, have been found to contain high levels of harmful bacteria.
Colgate-Palmolive announced additional developments and actions by the Company to protect consumers against possible risk from recently reported counterfeit toothpaste.
A new initiative from Columbia University Medical Center will be the first to target chronic oral health problems in sub-Saharan Africa, where the vast majority of chronic diseases are left undetected and untreated. The initiative is the result of an anonymous $1.5 million gift to support the Millennium Villages, which aims to fight extreme poverty and related challenges such as disease, hunger and lack of access to water and sanitation though scientifically sound and sustainable interventions. A third of the gift will be devoted to supporting the oral health program.
A study conducted in a large sample of postmenopausal women by University at Buffalo epidemiologists has provided new information on the prevalence of certain gum-disease-causing oral bacteria in this population and the association of the bacteria with oral bone loss.
Two new studies in the June issue of the Journal of Periodontology suggest that periodontal diseases are a threat to women of all ages due to hormonal fluctuations that occur at various stages of their lives.
GlaxoSmithKline plc announced results from an international, pivotal Phase III study of its investigational non-peptide oral platelet growth factor, Revolade? (eltrombopag). Data from this study showed that eltrombopag at 50-75mg once daily resulted in a statistically significant increase in platelet counts and also reduced bleeding in adult patients with chronic idiopathic thrombocytopenia purpura (ITP).